Design and action of steroidal aromatase inhibitors

JAOCS, Journal of the American Oil Chemists' Society

Volumn 73, Issue 11, 1996, Pages 1435-1451

  Li, Shengrong ^a   Parish, Edward J ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Action; Aromatase; Design; Inhibition; Inhibitor; Inhibitors; Steroid; Steroidal

Indexed keywords

AROMATIZATION; BIOSYNTHESIS; CHOLESTEROL; COMPOSITION EFFECTS; HORMONES; HYDROXYLATION; REACTION KINETICS;

AROMATASE; STEROIDS;

ENZYME INHIBITION;

EID: 0030287786     PISSN: 0003021X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02523508     Document Type: Article

References (90)

1. Ryan, K.J.J., Biological Aromatization of Steroids, J. Biol. Chem. 234:268-272 (1959).
2. Corbin, C.J., S. Graham-Lorene, M. McPhaul, J.I. Mason, C.R. Mendelson, and E.R. Simpson, Isolation of a Full-Length CDNA Insert Encoding Human Aromatase System Cytochrome P-450 and Its Expression in Nonsteroidogenic Cells, Proc. Natl. Acad. Sci. U.S.A. 85:8948-8953 (1988).
3. Thompson, E.A., and P.K. Siiteri, The Involvement of Human Placental Microsomal Cytochrome P-450 in Aromatization, J. Biol. Chem. 249:5373-5382 (1974).
4. Kellis, J.T., and L.E. Vickery, Purification and Characterization of Human Placental Aromatase Cytochrome P-450, Ibid. 262:4413-4420 (1987).
5. Osawa, Y., and T. Higanshiyama, Isolation of Human Placental Aromatase Cytochrome P-450 and Its Mechanism of Action of Androgen Aromatization in Microsomes, Drug Oxidation, R.W.J. Estabrook, Academic Press, Orlando, 1980, Vol. 1, pp. 115-248.
6. Simpson, E.R., and C.R. Hendelson, Tissue-Specific Promotors Regulate Aromatase Cytochrome P-450 Expression, J. Steroid Biochem. Molec. Biol. 44:4-6 (1993).
7. Koymans, L.M.H., H. Moereels, and H.V.J. Bossche, A Molecular Model for the Interaction Between Vorozole and Other Nonsteroidal Inhibitors and Human Cytochrome P-450 19 (P-450 Aromatase), Ibid. 53:191-197 (1995).
8. Brodie, A.M.H., Overview of Recent Development of Aromatase Inhibitors, Cancer Res. (Suppl.) 42:3312s-3319s (1983).
9. Brodie, A.M.H., L.Y. Wing, P. Goss, M. Dowsett, and R.C. Coombes, Aromatase Inhibitors and Their Potential Clinical Significance, J. Steroid Biochem. 25:859-865 (1982).
10. Kuhnel, R., J.F.M. Delemarre, B.R. Rao, and J.G. Stolk, Corre lation of Aromatase Activity and Steroid Receptors in Human Ovarian Carcinoma, Anticancer Res. 6:889-892 (1986).
11. MacDonald, P., R.R. Rombaut, and P.K. Siiteri, Plasma Precursors of Estrogen. I. Extent of Conversion of Plasma Delta-4-androstene-dione to Estrone in Normal Males and Nonpregnant Normal, Castrate and Adrenalectomized Females, J. Clin. Endoer. Metab. 27:1103-1112 (1967).
12. Jordan, V.C., Biochemical Pharmacoloty of Antiestrogen Action, Pharmacolotical Rev. 36:245-276 (1967).
13. Coombes, R.C., P. Goss, M. Dowsett, J.C. Gazet, and A.M.H. Brodie, 4-Hydroxyandrostenedione Treatment of Postmenopausal Patients with Advanced Breast Cancer, Lancet 2:1237-1239 (1984).
14. Coombes, R.C., P. Goss, M. Dowsett, J.C.M. Gazet, and A.M.H. Brodie, Treatment of Advanced Postmenopausal Breast Cancer with Aromatase Inhibitor, 4-Hydroxyandrostenedione Phase, Cancer Res. 46:4823-4826 (1986).
15. Brodie, A.H.M., Aromatase Inhibitors in the Treatment of Breast Cancer, J. Steroid Biochem. Molec. Biol. 49:281-287 (1994).
16. Thompson, E.A., and P.K. Siiteri, Utilization of Oxygen and Reduced Nicotinamide Adenine Dinucleotide Phosphate by Human Placental Microsomes During Aromatization of An-drostenedione, J. Biol. Chem. 249:5264-5271 (1974).
17. 19-14C] Androstenedione: A New Substrate for Assaying Aromatase and Studying Its Reaction Mechanism, Biochem. Biophys. Res. Commun. 157:81-86 (1988).
18. Akhtar, M., and G. Taylor, Studies on the Mechanism of Aromatase, Biochem. J. 75:75-81 (1969).
19. Fishman, J., and H. Hosoda, Unusually Facile Aromatization of 2β-Hydroxy-19-oxo-4-androstene-3,17-dione to Estrone, J. Am. Chem. Soc. 96:7325-7329 (1974).
20. Fishman, J., and J. Goto, Participation of a Nonenzymic Transformation in the Biosynthesis of Estrogens from Androgens, Science 195:80-81 (1977).
21. Fishman, J., and M.S. Raju, Mechanisms of Estrogen Biosynthesis. Stereochemistry of C-1 Hydrogen Elimination in the Aromatization of 2-Beta-hydroxy-19-oxoandrostenedione, J. Biol. Chem. 259:1689-1693 (1984).
22. Fishman, J., Aromatization of Androgens, Steroids 47:50-62 (1986).
23. 4-androstene-3,17-dione at a Common Catalytic Site in Human Placental Microsomes, Endocrinol. 71:723-728 (1962).
24. 4-androst-3,17-dione at a Common Catalytic Site in Human Placental Microsomes, Biochem. 16:140-146 (1977).
25. Bunsen, D.D., H.L. Carrell, and D.F. Covey, Metabolism of 19-Methyl-substituted Steroids by Human Placental Aromatase, Ibid. 26:7833-7841 (1987).
26. Wright, J.N., and M. Akhtar, Studies on Estrogen Biosynthesis Using Radioacative and Stable Isotopes, Steroids 55:142-151 (1990).
27. 1H]-3β-Hydroxyandrost-5en-17-ones by Human Placental Aromatase, J. Am. Chem. Soc. 108:1847-1852 (1986).
28. Akhtar, M., M.R. Calder, D.L. Corina, and J.N. Wright, Mechanistic Studies on C-(19 Demethylation in Estrogen Biosynthesis, Biochem. J. 201:569-580 (1982).
29. Soonsin, S.H., and C.H. Robinson, Mechanism of Human Placental Aromatase: A New Active Site Model, J. Steroid Biochem. Molec. Biol. 44:389-397 (1993).
30. Covey, D.E., and W.F. Hood, A New Hypothesis Based on Suicide Substrates Inhibitor Studies for the Mechanism of Action of Aromatase, Cancer Res. (Suppl) 42:3327s-3332s (1982).
31. Bensen, D.D., and D.F. Covey, Study of Role of Schiff Base Formation in the Aromatization of 3-[18O]-Testosterone and 3,17-Di[18O] Androstenedione by Human Placental Aromatase, J. Steroid Biochem. 4A:931-934 (1984).
32. Hahn, H.F., and J. Fishman, Immunological Probe of Estrogen Biosynthesis. Evidence for the 2-β-Hydroxylative Pathway in Aromatization of Androgens, J. Biol. Chem. 259:1689-1693 (1984).
33. Morand, P., D.G. Williamson, and D.S. Layne, Conversion of Androgen Epoxide into 17 β-estradiol by Human Placental Microsomes, Biochem. 14:635-642 (1975).
34. Morand, P., M. Kalapurackal, and L. Lompa-Krzymien, Steroid Oxides as Potential Precursors in Biosynthesis Estrogens, J. Theor. Biol. 56:503-511 (1976).
35. Morand, P., and L. Lompa-Krzymien, The Metabolism of the Epoxide of Testosterone by Human Placental Microsomes, Steroids 26:387-393 (1975).
36. Mastalerz, H., and P. Morand, Thermal Decarboxylation of 3,17-Dioxo-4β, 5-epoxy-5β androstan-19-oic Acid and Some Transformations of the Derived Product, J. Org. Chem. 1206-1208 (1981).
37. Mastalerz, H., and P. Morand, Acid- and Base-Catalysed Reaction of 4β,5β- and 4a,5a-Epoxyandrostane-3,17,19-trione, J. Chem. Soc. Perkin Trans. 1:2611-2615 (1982).
38. Brueggemeier, R.W., Biochemical and Molecular Aspects of Aromatase, J. Enzyme Inhib. 4:101-111 (1990).
39. Santen, R.J., Potential Clinical Role of New Aromatase Inhibitors, Steroids 50:1-665 (1987).
40. Dsamojlik, E., R.J. Santen, and S.A. Wells, Adrenal Suppression with Amino Glutenimide II Differential Effects of Aminoglutethimide on Plasma and Androstenedione and Estrogen Levels, J. Clin. Endocr. Metab. 45:480-487 (1977).
41. Stane, K.J., A. Alder, D. Bollus, A.S. Bhatnager, A. Haulser, and K. Schieweck, Synthesis and Aromatase Inhibitory Activity of Novel 1-(4-Aminopenyl)-3-Azabicyclo[3.1.0]hexane and - [3.1.1]heptane-2,4-diones, J. Med., Chem. 34:1329-1337 (1991).
42. McCagne, R., and M.G. Rowlands, Conformation Analysis of the Aromatase Inhibitor 3-Ethyl-3 (4-pyridyl) piperidine-2,6-dione (rogletimide) and Discovery of Potent 5-Alkyl Derivatives, Ibid. 35:3699 (1992).
43. Dowsett, M., F. MacNeil, S. Mehta, and C. Newton, Endocrine, Pharmacokinetic and Clinical Studies of the Aromatase Inhibitor 3-Ethyl-3-(4-pyridyl) piperidine-2,6-dione (pyrdoglutethimide) in Post-Menopausal Breast Cancer Patients, Br. J. Cancer 64:887-894 (1991).
44. Geelen, J.A.A., H.J.J. Lozen, G.H. Deckers, R. de Leeuw, H.J. Kloosterboer, and S.W.J. Lamberts, A New Highly Selective Orally Active Aromatase Inhibitor, J. Steroid Biochem. Molec. Biol. 44:4-6 (1993).
45. Browne, L.J., J. Gude, H. Rodriguez, R.E. Steele, Fadrozote Hydrochloride: A Potent, Selective, Nonsteroidal Inhibitor of Aromatase for the Treatment of Estrogen-Dependent Disease, J. Med. Chem. 34:725-736 (1991).
46. Furet, P., C. Batzl, A. Bhatnagar, E. Francotte, G. Rihs, and M. Lang, Aromatase Inhibitors: Synthesis, Biological Activity, and Binding Mode of Azole-type Compounds, Ibid. 36:1393-1400 (1993).
47. Van Wayne, J.P., and P.A.J. Janssen, Is There a Case For P-450 Inhibitors in Cancer Treatment? Med. Chem. 32:2231-2239 (1989).
48. Wonters, W., R. Decoster, D. Beerens, and R. Doolaege, Potency and Selectivity of the Aromatase Inhibitor R 76713 a Study in Human Ovarian Adipose Stromal, Testicular and Adrenal Cells, J. Steroid, Biochem. Molec. Biol. 36:57-65 (1990).
49. Ploude, P.V., M. Pyroff, and M. Dukes, Arimidex: A Potent and Selective Fourth-Generation Aromatase Inhibitor, Breast Cancer, Res. Treat. 35:276-285 (1994).
50. Bhatnagar, A.S., A. Hausler, P. Trunet, K. Schieweck, M. Lang, and P. Bowman, Highly Selective Inhibition of Estrogen Biosynthesis by Cgs 20267 A New Nonsteroidal Aromatase Inhibitor, J. Steroid Biochem. Molec. Biol. 37:1021-1027 (1990).
51. Demers, L.M., A. Lipton, and H.A. Harvey, The Effects of CGs 20,267 in Suppressing Estrogen Biosynthesis in Patients with Breast Cancer, Ibid. 44:687-691 (1993).
52. Schwarzel, W.C., W.G. Kruggel, and H.J. Brodie, Studies on the Mechanism of Estrogen Biosynthesis. VII. The Development of Inhibitors of the Enzyme System in Human Placenta, Endocrinol. 92:866-871 (1973).
53. Marsh, D.A., H.J. Brodie, W. Garrett, C.H. Tsai-Morris, and A.M.H. Brodie, Aromatase Inhibitors-Synthesis and Biological Activity of Androstenedione Derivatives, J. Med. Chem. 25:788-796 (1985).
54. Brodie, A.M.H., N. Garrett, and J.R. Hendrickson, Inactivation of Aromatase in vitro by 4-OHA and 4-Acetoxyandrostenedione and Sustained Effects in vivo, Steroids 35:693-897 (1981).
55. Lombardi, P., Proceedings of the Seventh Conference on Hormonal Steroids, Barcelona, Spain, Plenum Press, New York, 1986, pp. 93-105.
56. Marsh, D.A., H.J. Brodie, W. Garrett, C.H. Tsai-Morris, and A.M.H. Brodie, Aromatase Inhibitors-Synthesis and Biological Activity of Androstenedione Derivatives, J. Med. Chem. 28:788-796 (1985).
57. Abuj-Haij, Y.J., Synthesis and Evaluation of 4-(Substituted thio)-4-androstene-3,17-dione Derivatives as Potential Aromatase Inhibitors, J Med. Chem. 29:582-584 (1986).
58. Furth, P.S., J. Rosenberger, P.A. Marcotte, and C.H. Robinson, Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17 dione An Inhibitor of Aromatase, J. Enzyme Inhib. 4:131-135 (1990).
59. Henderson, D., U.F. Habenicht, Y. Nishino, and M.F. Ei Etreby, Estrogens and Benign Prostatic Hypertrophy: The Basis for Aromatase Inhibitor Therapy, Steroids 50:219-233 (1987).
60. Miyairi, S., and J. Fishman, 3-Methylene-Substituted Androgens as Novel Aromatization Inhibitors, J. Biol. Chem. 261:6772-6779 (1986).
61. Bruggemeier, R.N., E.Z. Floyd, and R.E.J. Counsell, Med. Chem. 21, 1007-1011 (1978).
62. Holland, H.L., S. Kumaresan, L. Tan, and V.C.O. Njar, Synthesis of 6-Hydroxyimino-3-oxo Steroids, A New Class of Aromatase Inhibitor, J. Chem. Soc. Perkin Trans. 1:585-592 (1992).
63. Covey, D.F., and W.F. Hood, Enzyme-Generated Intermediates Derived from 4-Androstene-3,6,17-trione and 1,4,6-Androstatriene-3,17 dione Cause a Time-Dependent Decrease in Human Placental Aromatase Activity, Endocrinology 108:1597-1599 (1981).
64. Giudici, D., G. Ornati, G. Briatico, F. Buzzett, D. Lombardi, and E. Di Salle, Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A New Irreversible Aromatase Inhibitor, J. Steroid Biochem. Molec. Biol. 30:391-394 (1988).
65. Giudici, D., G. Ornati, G. Briatico, F. Buzzetti, D. Lombardi, and E. Di Salle, Novel Aromatase and 5α-Reductase Inhibitors, Ibid. 49:289-294 (1994).
66. Numazawa, N., M. Tsuji, and Y. Osawa, Synthesis and Evaluation of Bromo-acetoxy 4-androsten-3-ones as Active Site-Directed Inhibitors of Human Placental Aromatase, Steroids 48:346-352 (1986).
67. Mann, J., and B. Pietrzak, The Synthesis of 4-Hydroxyandrost-4-ene-3,17 Dione and Other Aromatase Inhibitors, J. Chem. Soc., Perkin Trans. 1:2681-2690 (1983).
68. Tan, L., and A. Petit, Inactivation of Human Placental Aromatase by 6α-and 6β-Hydroperoxyandrostene-dione, Biochem. Biophys. Res. Commun., 128:613-620 (1989).
69. Brueggemeier, R.W., and P.K. Li, Steroidal Inhibitors as Chemical Probes of the Active Site of Aromatase, J. Steroid Biochem. Molec. Biol. 44: 357-365 (1993).
70. Bruggemeier, R.W., New Inhibitiors of Aromatase, J. Med. Chem. 38:378-384 (1995).
71. Panzeri, A., G. Ornati, E. Di Salle, and P. Lombardi, Synthesis and Biochemical Evaluation of the Novel Steroid Androsta-4,6,8 Triene-3,17-dione, J. Enzyme Inhib. 4:121-129 (1990).
72. Longcope, L., A.M. Femino, and J.O. Johnston, Inhibition of Peripheral Aromatization in Baboons by an Enzyme-Acativated Aromatase Inhibitor of Estrogen Biosynthesis, Endocrinol. 115:76-84 (1984).
73. Johnston, J.O., Biological Characterization of 10-(2-Propynl)estr-4-ene-3,17-dione (MDL 18,962) an Enzyme-Activated Inhibitor of Aromatase, Steroids 50:106-113 (1993).
74. Johnston, J.L., C.L. Wright, and B.W. Metcalf, Biochemical and Endocrine Properties of a Mechanism-Based Inhibitor of Aromatase, Endocrinol, 115:776-785 (1984).
75. Johnston, J.O., C.L. Wright, B.W. Metcalf, Time-Dependent Inhibitor of Aromatase in Trophoblastic Tumor Cells in Tissue Culture, J. Steroid Biochem. 20:1221-1231 (1984).
76. Mann, J., and B. Pietrzak, Preparation of Aromatase Inhibitors Synthesis of 19,19-Difluor-4 hydroxy androst-4-ene-3,17-dione and Related Compounds, J. Chem. Soc., Perkin Trans 1:385 (1989).
77. Covey, D.F., and M.F. Hood, 10β-Propynyl-Substituted Steroids, J. Biol. Chem. 256:1076-1082 (1981).
78. Marcotte, P.A., and C.H. Robinson, Inhibition and Inactivation of Estrogen Synthase (Aromatase) by Fluorinated Substrate Analogues, Biochemistry 21:2773-2782 (1982).
79. Nelson, S.D., and P.J. Bednarsk, Interaction of Thiol-Containing Androgens with Human Placental Aromatase, J. Med. Chem. 32:203-210 (1989).
80. Mann, J., and B. Pietrzak, The Synthesis of 4-Hydroxyandrost4-ene-3,17 dione and Other Potential Aromatase Inhibitors, J. Chem. Soc., Perkin Trans 1:2681-2690 (1983).
81. Kelli, J.T., and L.E. Vickery, Inhibition of Aromatase Cytochrome P-450 by 10-Oxirane and 10-Thirane Substituted Androgens, J. Biol. Chem., 262:4421-4426 (1987).
82. Johnston, J.O., L. Wright, J.P. Burkhart, and N.P. Peet, A-Ring Bridged Steroids as Potent Inhibitors of Aromatase, J. Steroid Biochem. Molec. Biol. 44:409-420 (1993).
83. Nelson, D.R., and H.W. Strohl, Secondary Structure Prediction of 52 Membrane-Bound Cytochromes P-450 Shows a Strong Structural Similarity to P-450 Cam, Biochem. 28:656-660 (1989).
84. Ouzounis, C.A., and W.T. Melvin, Primary and Secondary Structural Patterns in Eukaryotic Cytochrome P-450 Families Correspond to Structures of the Helix-rich Domain of Pseudomonas putida Cytochrome P-450 Cam, Eur. J. Biochem. 198:307-315 (1991).
85. Edwards, R.J., B.P. Murray, A.R. Bobis, and D.S. Davis, Identification and Location of α-Helices in Mammalian Cytochromes P-450, Biochem. 28:3762-3770 (1989).
86. Zrelebil, M.J.J.M., C.R. Wolf, and M.J.E. Sternberg, A Predicted Three-Dimensional structure of Cytochrome P450: Implications for Substrate Specificity, Protein Engng. 4:271-282 (1991).
87. Koymans, L.M.H., H. Moereels, and H.V. Bossche, A Molecular Model for the Interaction Between Vorozole and Other Nonsteroidal Inhibitors and human Cytochrome, J. Steroid, Biochem. Molec. Biol. 53:191-197 (1995).
88. Graham-Lorence, S., and M.W. Khalil, Structure-Function Relationships of Human Aromatase Cytochrome P-450 Using Molecular Modeling and Site-Directed Mutagenesis, J. Biol. Chem. 266:11939-11946 (1991).
89. Zhou, D., R. Korzekwak, T. Poulas, and S. Chen, A Site-Directed Mutagenesis Study of Human Placental Aromatase, Ibid. 267:762-768 (1992).
90. Loughton, C.A., M.J.J.M. Zrelebil, and S. Neidle, A Detailed Molecular Model for Human Aromatase, J. Steroid Biochem. Molec. Biol. 44:399-407 (1993).